GC Cell Set to Participate in the US Cancer Moonshot Project


Initiative aims to reduce cancer mortality rates by 50% in the next 25 years.

Disease dementia, memory loss. Human losing parts of head as symbol of decreased mind function alzheimer. Generation AI. Image Credit: Adobe Stock Images/Adin

Image Credit: Adobe Stock Images/Adin

GC Cell announced in a company press release that it will be joining CancerX, part of the US Cancer Moonshot project. Started by the Biden administration, the Cancer Moonshot aims to reduce cancer patient mortality rates by over 50% over the next 25 years. According to the company, it aims to highlight the importance and potential of cell therapy in cancer treatment through participating in the initiative.

"I am pleased to contribute to projects that can change the lives of many patients and their families,” said James Park, CEO, GC Cell.” “The Cancer Moonshot & CancerX provides an expanded opportunity to build diverse collaborative research and partnership frameworks with global companies."

Reference: GC Cell Joins US Cancer Moonshot Project. PR Newswire. October 24, 2023. Accessed October 25, 2023. https://www.prnewswire.com/news-releases/gc-cell-joins-us-cancer-moonshot-project-301966721.html

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.